Running Title; CRISPR analysis of an enhancer controlling ethanol intake.
Abstract.
Excessive alcohol intake is associated with 5.9% of global deaths. However, this figure is especially acute in men such that 7.6% of deaths can be attributed to alcohol intake against only 4% in women. Previous studies identified a significant interaction between haplotypes of the GAL gene with anxiety and alcohol abuse in different male populations but were unable to define a mechanism. To address these issues the current study analysed the human UK Biobank cohort and identified a significant interaction (n=115,865; p=0.0008) between allelic variation (GG or CA haplotypes) in the highly conserved human GAL5.1 enhancer, alcohol intake (AUDIT questionnaire scores) and anxiety in men that was consistent with these previous studies. Critically, disruption of GAL5.1 in mice using CRISPR genome editing significantly and specifically reduced GAL expression in amygdala and hypothalamus whilst producing a corresponding reduction in ethanol intake in KO mice. Intriguingly, we also found reduced anxiety in male animals lacking GAL5.1 demonstrating sexual dimorphism mirroring that seen in humans. Using bioinformatic analysis and co-transfection studies we further identified the EGR1 transcription factor, that is co expressed with GAL in amygdala and hypothalamus, as being important in the PKC supported activity of the GG haplotype of GAL5.1 but less so in the CA haplotype. Our unique study uses a novel combination of human association analysis, CRISPR genome editing in mice, animal behavioural analysis and cell culture studies to identify a highly conserved regulatory mechanism linking anxiety and alcohol intake that might contribute to anxiety induced alcohol abuse in men.
Background.
The relationship between alcohol abuse and anxiety has been extensively explored 1 but the genomic mechanisms linking them remain poorly understood. Previous studies have
shown that the galanin neuropeptide (encoded by the GAL gene) influences alcohol intake 2, 3 and mood 4 . Moreover, genetic analyses of different haplotypes within the GAL locus succeeded in identifying an association with excess alcohol intake that was influenced by sex and axiety 5 . Unfortunately, these studies were unable to define a mechanism to explain these interactions as the GAL coding region lacks non-synonymous polymorphisms 5 . Although there is a possibility that mis-regulation of GAL may affect alcohol intake and anxiety, little is known of the genomic mechanisms that modulate the expression of the GAL gene in the brain.
Based on the hypothesis that many regions of the genome that control gene expression are essential to species fitness are conserved through evolution 6, 7 , we undertook a comparative genomic analysis of the genome surrounding the human GAL locus and succeeded in identifying a highly conserved enhancer sequence (hGAL5.1) 42 kilobases (kb) from the GAL gene transcriptional start site. We demonstrated that GAL5.1 was active in galanin expressing cells of the hypothalamus including the PVN and dorsomedial hypothalamus (DMH) 8 . We also found that GAL5.1 contained two polymorphisms in perfect linkage disequilibrium (LD; rs2513280 (C/G) and rs2513281 (A/G)) that produced two different haplotypes (GG and CA) within the human population and reported that the major GG haplotype was significantly more active in primary hypothalamic neurones than the minor CA haplotype 8 . Subsequent analysis of these haplotypes in human populations detected an association of the GG haplotype and volume of alcohol intake in women in a small US cohort (n=138) 9 . However, a second UK (n=2731) and US cohort (n=4064) based study, although initially identifying an association to increased frequency of binge drinking in teenagers, failed to reach significance after correction for multiple comparison 10 . Because of the comparatively small size of these studies we interrogated a much larger human cohort (UK biobank) to better determine the association of specific allelic variants in GAL5.1 with levels of alcohol intake and anxiety in UK men and women. In addition, we used cutting edge CRISPR genome editing to disrupt GAL5.1 in mice and examined the effects on the expression of flanking genes in areas of the brain including the hypothalamus and the amygdala to functionally link GAL5.1 activity to the expression of five flanking genes including Gal. Our study also characterises the effects of GAL5.1 disruption on ethanol consumption and anxiety behaviour in mice. A combination of bioinformatics (DNAseI hypersensitivity) and co-transfection studies also identified a transcription factor-DNA interaction underpinning GAL5.1 function and its response to signal transduction cues. This study highlights a mechanistic link between ethanol consumption and anxiety centred on the GAL5.1 enhancer that may contribute to the development of alcohol abuse and anxiety in men 11, 12 .
Methods. score as the outcome variable we performed linear regression using age fitting 20 genetics principal components as fixed effect covariates. rs2513280 was fit as a main effect (coded 0,1,2 corresponding to the number of C alleles carried) alongside anxiety and sex and then fitting a three-way interaction term of sex*anxiety*rs2513280.
Generation of gRNA molecules by a novel annealed oligo template (AOT) method.
Single guide RNA (sgRNA) molecules were designed to disrupt the GAL5.1 enhancer (Fig. 1) using the optimised CRISPR design tool (http://CRISPR.mit.edu/). sgRNA template was produced by annealing two oligonucleotides. The first was a generic 80mer (5'-AAA AAA AGC   ACC GAC TCG GTG CCA CTT TTT CAA GTT GAT AAC GGA CTA GCC TTA TTT TAA CTT GCT ATT TCT AGC TCT AA-3') that represented the sgRNA scaffold and was called the template scaffold oligo. The second oligonucleotide was termed the sgRNA specific oligo (63mer; 5'-TTA ATA CGA CTC ACT ATA GGN NNN NNN NNN NNN NNN NNN GTT TTA GAG CTA GAA ATA GCA AG -3') where "N" denotes the predicted guide sequence (5'sgRNA;
CTC CCT GGA GCA ATA TGA AG and 3'sgRNA; CCC GCT TTC ATG GCT CCC AA).
Underlined sequence represents the T7 promoter and italic sequence represents sequence complimentary to the template scaffold oligo. These oligonucleotides were annealed and amplified using PCR to produce a 122 bp double strand sgRNA template. 100 ng of this template was used to produce sgRNA using a mMESSAGE mMACHINE T7 in-vitro transcription kit (Ambion) described in the manufacturer's instructions and purified using a
Megaclear kit (Ambion) with modifications as previously described 16 .
Production of genome edited mice. sgRNA molecules were microinjected at a concentration 10 ng/µl each into the cytoplasm of 1-cell C57/BL6 embryos as described 16 together with 10 ng/µl CAS9 mRNA (Life Technologies). Two-cell embryos were introduced into host CD1 mothers using oviduct transfer as previously described 17 and correctly targeted offspring were determined by PCR of earclip DNA using the following flanking primers (mGAL5for; AGTTAGGGCGCACACATCAA, mGAL5rev; CCGTGACTAACG GCTAATGC).
In-situ Hybridisation. Radioactive in-situ hybridisation was carried out on 10μm brain sections derived from wild type mice using radiolabelled Gal or EGR1 antisense RNA probes as previously described 18 .
Quantitative reverse transcriptase-PCR. Brain tissues (Hypothalamus, amygdala, hippocampus and cortex) were dissected and snap frozen on dry ice. Total RNA was extracted using the isolate II RNA minikit (Bioline Data analysis. From in-vivo pilot studies we calculated that a minimum of 6-12 animals per group would enable detection of a 25% difference between different parameters (ethanol intake, fat deposition) with 80% power using one-way ANOVA and/or general linear modelling.
Statistical significance of data sets was analysed using either one-way analysis of variance (ANOVA) analysis with Bonferroni post hoc tests or using one tailed or two tailed unpaired parametric Student t-test as indicated using GraphPad PRISM version 5.02 (GraphPad Software, La Jolla, CA, USA).
Results.
The G-allele of rs2513280 associates with increased alcohol consumption in women. In order to test the validity of two previous association analyses 9, 10 we investigated whether there was an association between allelic variants of the GAL5.1 enhancer and increased alcohol intake in a much larger cohort comprising 345,140 individuals (UK Biobank;
183,921 females and 161,219 males). In the total sample an association between the G allele of rs2513280 (a proxy for both loci) and increased weekly alcohol intake was identified (b=0.008, s.e.=0.004, p=0.0463). When analysing males and females separately, the association between male alcohol intake and rs2513280 became non-significant (b=0.004, s.e.=0.006, p=0.478); however, in females the association was stronger and remained significant (b=0.012, s.e.=0.006, p=0.037).
Because of the known link between anxiety and alcohol abuse in men 5 we further investigated the interaction of these variables with respect to the rs2513280 using a subset of the UK Biobank that also contained information relating to anxiety 15 . There was an effect of male sex on AUDIT score with males having significantly higher AUDIT scores than females (b=0.34, S.E.=0.005, p < 2 x 10 -16 ). Individuals with higher levels of self-reported anxiety also had significantly higher AUDIT scores although there was no main effect of the rs2513280 polymorphism. No significant interactions were detected between sex and rs2153280 or anxiety and rs2513280 (Fig 1A) . However, anxious males reported significantly higher AUDIT scores (p=0.0008) if they carried the major allele at the rs2153280 locus (Fig 1A and B) . 
Disruption of GAL5.1 reduces expression of GAL throughout the brain but does not affect the expression of flanking genes.
We compared the expression of the GAL gene in mRNA derived from various regions of the brain in wild type and mGAL5.1KO mice.
Expression of GAL mRNA was strongest in the hypothalamus and the amygdala with some evidence of GAL mRNA expression in hippocampus and cortex (Fig 3A and B) . We observed that expression of Gal became almost undetectable in all these tissues in GAL5.1KO animals ( Fig 3A and B) suggesting that GAL5.1 is essential for global Gal expression.
We also analysed the influence of mGAL5.1 disruption on the expression of Gal and 4 other flanking genes flanking the Gal locus namely Lrp5, Ppp6r3 (5' of GAL5.1) Mtl5 and Cpt1a (3'of GAL5.1) that are all maintained in the same synteny block 24 in both humans and mice spanning 536kb in humans and 379kb in mice (Fig 3C) . Although we found strong down regulation of the Gal gene we saw no significant change of expression in any of the flanking genes suggesting a lack of requirement for GAL5.1 for expression of these genes (Fig 3D) 25 .
mGAL5.1KO animals exhibit a decreased preference for ethanol.
Because the GAL gene has been shown to control intake of alcohol 2, 3 and that a polymorphism within the GAL5.1 enhancer was associated with increased alcohol intake in women we tested the hypothesis that disruption of the mGAL5. (Fig 4 G and   L) . The reduced length of time spent by males in the periphery was balanced against the increased time spent in the centre of the arena and an increased number of centre entries (Fig   4 H and I ). This contrasts with female mice whose centre time and centre entry number was not affected by disruption of GAL5.1 (Fig 4 M and N) and provides evidence of a differing role for GAL5.1 in anxiety related behaviours between males and females that parallels that observed in humans.
The EGR1 transcription factor interacts with GAL5.1 and contributes in response to PKC activation. To identify transcription factors that were involved in modulating GAL5.1 activity we undertook a bioinformatic analysis of the GAL5.1 enhancer using ENCODE data on the UCSC browser (Fig 5A) . ENCODE identified highly conserved regions of GAL5.1 that were sensitive to DNAse1 digestion; a diagnostic of open, transcriptionally active chromatin, in several different cell lines (Fig 5A and B) . This analysis also highlighted the presence of a highly conserved binding consensus of EGR transcription factors that lay within a DNAseI hypersensitive region (Fig 5A and B) . Furthermore, EGR1 (AKA Zif268) is expressed in the PVN (Fig 5C) and up-regulated in the ARC in response to anorexia stimulated melanocortin signalling 26 . We produced luciferase reporter constructs containing the GAL5.1(GG) enhancer and a derivative of GAL5.1(GG)lacking the conserved EGR binding site. These were transfected into a neuroblastoma cell line (SH-SY5Y) in the absence/presence of an expression vector expressing the EGR1 protein (pcDNA3-EGR1, Addgene). These experiments demonstrate that expression the EGR1 transcription factor in SH-SY5Y significantly increased GAL5.1 activity (Fig 5D) . Critically, deletion of the conserved EGR1 binding site shown in Fig 5B significantly reduces the activity of GAL5.1 in the presence of EGR1 expression. We also show that treatments with 100nM of the PKC agonist phorbol ester PMA further up-regulated GAL5.1 activity in the presence of EGR1 27-29 which was abolished in the absence of the EGR1 binding site (Fig 5E) . Further analysis comparing the effects of EGR1 expression and PKA stimulation on the GAL5.1(GG) and GAL5.1(CA) haplotype reporter constructs showed that whilst the GG haplotype responded strongly to EGR1 expression in SH-SY5Y cells the CA haplotype did not. In addition, the PKA response of the CA haplotype was blunted in comparison to the GG haplotype of GAL5.1 (Fig 5F) .
Discussion.
Understanding the processes that modulate preference for ethanol is particularly pressing in men where 7.6% of all male deaths globally is attributable to alcohol (4% in women) through Intriguingly, this study also uncovered evidence of a sex specific role for anxiety in modulating alcohol intake 32 . Unfortunately, the authors were unable to identify a molecular mechanism that could account for their findings. The current study took an entirely different approach and explored the problem from the initial standpoint of functionality. This was achieved by analysing the effects of polymorphisms known to change the activity of the highly conserved GAL5.1 enhancer sequence found 42kb from the GAL gene 8 .
We began our analysis of a possible role for the GAL5.1 enhancer in alcohol intake by interrogating the UK Biobank cohort to determine the validity of previous conflicting smaller scale association studies 9, 10 . Our analysis supported observations by Nikolova et al (2013) who reported an association between the G-allele of GAL5.1 and increased alcohol intake in women 9 but not in men. Because anxiety has been identified as an important variable influencing alcohol intake in humans 1 and had also been identified as being an important variable in modulating the role of the GAL gene in alcohol intake 32 , we carried out a deeper analysis of the rs2513280 polymorphism UK biobank by stratifying alcohol intake with anxiety.
We were surprised to find a significant association between reported anxiety and drinking behaviour in men which was not observed in women. This observation was entirely consistent with previous reports of sexual dimorphism on the influence of the GAL locus on mood and alcohol intake 32 .
To further explore the role of GAL5.1 in ethanol intake and anxiety we disrupted GAL5.1 in mice using CRISPR/CAS9 genome editing using a novel method of generating gRNA which greatly increased the speed and efficiency of the process. Using QrtPCR of different brain regions of GAL5.1 knock out mice we found that disruption of GAL5.1 virtually blocked expression of Gal mRNA expression in hypothalamus, amygdala, hippocampus and cortex consistent with a requirement for GAL5.1 for expression of Gal in these brain regions.
Moreover, analysis of gene expression of four other flanking genes suggested that GAL5.1 is specific in its modulation of the expression of the Gal gene. However, the most striking outcome of the current study was the observation that CRISPR/CAS9 disruption of GAL5.1 significantly reduced preference for ethanol in mice demonstrating a key role for GAL5.1 in ethanol intake. Analysis of our GAL5.1 KO mice also found sexual dimorphism in the effects of GAL5.1 disruption on anxiety such that male mice demonstrated a significant reduction in anxiety-related behaviour which was not reflected in female GAL5.1KO mice. These observations are entirely consistent with our stratified analysis of the UK biobank cohort where increased anxiety was associated with increased alcohol intake in men but not in women and in previous analysis of polymorphisms around the GAL gene 32 . That patterns of male orientated anxiety and alcohol intake around a GAL5.1 haplotype should so closely parallel the ethanol intake and anxiety phenotypes identified in our analysis of the GAL5.1 disruption in mice suggests that a common, and highly conserved, mechanism governing mood and ethanol intake exists at the GAL5.1 locus. From a mechanistic standpoint it is worth considering that the observed sexual differences observed in anxiety and alcohol intake in both humans and mice may be influenced by previously observed modulation of the GAL gene promoter by the estrogen receptor 33, 34 .
Several studies have identified genetic associations between polymorphisms around the human GAL locus and mood disorders [34] [35] [36] . In the current study we demonstrate that down regulation of galanin expression throughout the brain by disruption of the GAL5.1 enhancer causes significant changes in the anxiety-like behaviour of male mice subjected to the open field test. Although the current study is currently unable to confirm which areas of the brain are responsible for this sex specific change in behaviour we show that Gal expression was reduced in the amygdala following disruption of GAL5.1. However, we concede that, given the known complexity of the galaninergic system in modulating mood 37 , it would be premature to link the change in anxiety observed in our study with a change of expression in the amygdala.
Although the specific role of GAL expression in the amygdala in modulating mood requires more study, the discovery of an enhancer that drives expression of GAL in the limbic system and which, when disrupted, alters mood affords unique possibilities for understanding the molecular mechanisms contributing to anxiety disorders that remain one of the most common co-morbidities associated with alcohol abuse 31 .
Closer analysis of the GAL5.1 sequence using a combination of bioinformatics and cell co-transfection studies suggested a functional interaction between the EGR1 transcription factor and a highly conserved EGR binding site within a highly conserved region of GAL5.1. In addition, we were able to demonstrate a role for the EGR1 transcription factor in modulating previously identified PKA induced activity of GAL5.1 8 . EGR1 has a high affinity for DNA and is known to be able to bind DNA even when methylated 38 . Thus, it is entirely possible that EGR1 acts as a "pioneer factor" by being one of the first transcription factors that bind to the closed and methylated GAL5.1 locus thus activating its tissue specific activity. Interestingly, we observed that the CA allele of GAL5.1 did not respond to EGR1 expression and its PKC response was blunted. This is an interesting observation as the EGR1 binding site in GAL5.1 is 100bp from the closest of the SNPs making up the CA haplotype (rs2513281). We propose that the EGR1 protein forms part of a larger protein complex that interacts across the whole of the most conserved regions of the GAL5.1 enhancer. It is therefore possible that EGR1 binding and GAL5.1 function is dependent on binding of another, as yet unidentified, protein whose binding is interrupted by one of the allelic variants of GAL5.1 thus affecting EGR1 binding.
Conclusion.
To the best of our knowledge, this is the first time that the unique combination of techniques used in our study; human association analysis, comparative genomics and CRISPR/CAS9 genome editing, have been used to establish a functional role for a tissue-specific enhancer region in alcohol selection and mood in living animals. This study is given even greater impact by our analysis of the UK biobank cohort that demonstrates a link between increased alcohol intake and anxiety in men paralleling that seen in our CRISPR derived models. Placing the current study within a wider context of understanding the mechanistic basis of complex human disease it is clear that an important step has been made in bridging the gap between association analysis and mechanism especially in light of the fact that the majority of associated SNPs generated by GWAS are in the non-coding genome 39 . Although histone markers (H3K4me1) and GWAS can identify candidate regulatory regions affected by disease associated polymorphic variation on a genome wide level the current study serves to emphasise that there is also merit in the use of comparative genomics and functional characterisation of the cell specific activity of putative regulatory elements using CRISPR genome editing in whole animal systems. 
Declaration of interest. None of the authors declare any conflicts of interest
References. 
